Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Jacobs

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Vaccines|September 27, 2025
A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older AdultsValentino D'Onofrio, Bart Jacobs, Azhar Alhatemi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximabBart Jacobs, Wendy De Roock, Hubert Piessevaux, et al.
International Journal of Cancer|February 14, 2013
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapyEmanuele Valtorta, Sandra Misale, Andrea Sartore-Bianchi, et al.
The Journal of Infectious Diseases|June 10, 2024
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 StudyIsabel Leroux-Roels, Cathy Maes, Francesca Mancini, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
The Lancet. Infectious Diseases|July 28, 2024
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trialIsabel Leroux-Roels, Chittappen Kandiyil Prajeeth, Amare Aregay, et al.
Frontiers in Cardiovascular Medicine|June 21, 2024
Lung transplantation following controlled hypothermic storage with a portable lung preservation device: first multicenter European experienceAn-Lies Provoost, Rene Novysedlak, Dirk Van Raemdonck, et al.
The New England Journal of Medicine|September 27, 2023
Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICUJan Gunst, Yves Debaveye, Fabian Güiza, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Vaccines|September 27, 2025
A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older AdultsValentino D'Onofrio, Bart Jacobs, Azhar Alhatemi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximabBart Jacobs, Wendy De Roock, Hubert Piessevaux, et al.
International Journal of Cancer|February 14, 2013
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapyEmanuele Valtorta, Sandra Misale, Andrea Sartore-Bianchi, et al.
The Journal of Infectious Diseases|June 10, 2024
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 StudyIsabel Leroux-Roels, Cathy Maes, Francesca Mancini, et al.
JCO Precision Oncology|February 1, 2022
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor TherapyJoan Maurel, Vicente Alonso, Pilar Escudero, et al.
The Lancet. Infectious Diseases|July 28, 2024
Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trialIsabel Leroux-Roels, Chittappen Kandiyil Prajeeth, Amare Aregay, et al.
Frontiers in Cardiovascular Medicine|June 21, 2024
Lung transplantation following controlled hypothermic storage with a portable lung preservation device: first multicenter European experienceAn-Lies Provoost, Rene Novysedlak, Dirk Van Raemdonck, et al.
The New England Journal of Medicine|September 27, 2023
Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICUJan Gunst, Yves Debaveye, Fabian Güiza, et al.
Pageof 8